Near Normalisation of BG Improves the Potentiating Effect of GLP-1
NCT00612625
·
clinicaltrials.gov ↗
NA
Phase
COMPLETED
Status
9
Enrollment
OTHER
Sponsor class
Conditions
Diabetes Mellitus Type 2
Interventions
DRUG:
glucagon-like peptide-1
DRUG:
Saline
Sponsor
Hvidovre University Hospital